Company profile
APIM Therapeutics company profile
APIM Therapeutics is based on an original discovery by Prof. Marit Otterlei and co-inventors at the Department of Cancer Research and Molecular Medicine at NTNU (Trondheim, Norway). The company is currently developing proprietary peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen), a key DNA repair protein regulating cellular responses to DNA damage and stress.
Business identity
- Contact email
- [email protected]
- Phone number
- +47 73 49 4002
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $0+
- Founded
- 2009-01-01
Headquarters
- Headquarters
- Trondheim, Trøndelag, Norway
- Postal code
- N-7491
- Country code
- NO
- Continent
- Europe